Physician profile
Robert Baber
NPI 1881099141
$995.72
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $321 · 2023: $285 · 2024: $67.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $252.59 | 2021-2023 | Xarelto |
| Medtronic, INC. | $177.79 | 2022-2024 | In.Pact Admiral, Endurant Iis, Viance |
| Astrazeneca Pharmaceuticals LP | $120.30 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $101.32 | 2021-2023 | Eliquis |
| Endologix LLC | $93.60 | 2022 | |
| Bolton Medical INC | $59.03 | 2021-2023 | Treo Abdominal Stent-Graft System |
| Cvrx, INC. | $24.54 | 2023 | Barostim Neo System |
| Cardiovascular Systems INC. | $23.21 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.93 | 2021 | |
| Organogenesis INC. | $20.54 | 2022 | |
| Bard Peripheral Vascular, INC. | $20.10 | 2021 | |
| Urgo Medical North America, LLC | $18.95 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Boston Scientific Corporation | $16.97 | 2023 | |
| W. L. Gore & Associates, INC. | $16.35 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $15.96 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.